HYDERABAD, NOVEMBER 04, 2022 (GPN):  Aragen Life Sciences, a leading research and development services outsourcing partner to global pharmaceutical firms, has announced that its CEO, Mr. Manni Kantipudi, has won the prestigious ‘CEO of the Year’ Award at the CPHI Pharma Awards 2022 held in Messe Frankfurt, Germany. Manni was recognized for his dynamic leadership, his vision to create a sustainable organization, and his ability to lead the Aragen team toward a common goal by bringing together their collective strengths and capabilities.

The CPHI Pharma Awards celebrates the brightest individuals and companies with the winners selected for their contribution to the field of pharma drug delivery and sustainable growth strategies through innovation in products. The recognition also showcases world-class technologies and solutions for drug development and clinical research.

Under Manni’s leadership, Aragen has evolved to be a global contract service provider for small molecules and biologics. It has continuously expanded its service portfolio, made strategic acquisitions in India and the US, certified by GPTW three times in a row, achieved Silver rating for its sustainability initiatives by EcoVadis and is a part of various global sustainability initiatives, such as SBTi, PSIC, UNGC and many others.

Mr. Manni Kantipudi was chosen from a shortlist of six candidates across the globe for demonstrating keen ability to engage staff and customers, while remaining committed to the development of the global contract research and manufacturing industry.

About Aragen Life Sciences:

Aragen Life Sciences is a leading R&D and manufacturing solutions provider to the global life sciences industries. Aragen offers a range of solutions across the drug development continuum to advance small and large-molecule programs.  With more than 20 years of experience, the Company operates through a global network of eight sites with a team of ~4000 employees and 470+ PhDs. Its expertise and experience have enabled over 450 customers (including 6 of the top 10 pharma companies globally) in advancing their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally. Visit www.aragen.com for more details.